American Journal of Hematology · 2000 · 17 citations · 18 references
Life SciencesImmunologyPathologyApoptosisAutoimmunityImmunopathologyApoptosis In Immune CellsImmune Cell SignalingImmune FunctionImmune ResponseMacrophage BiologyActivation-induced Cell DeathCell ActivationFas LigandFas Ligand-mediated ApoptosisFas-associated Death Domain ProteinImmune System DisruptionMacrophage Apoptosis
Derailed T-cell activation can give rise to life-threatening macrophage activation, the final common pathway of the different forms of reactive macrophage activation syndromes (rMAS). Besides inappropriate activation of the immune system, impaired termination of immune responses might be another mechanism leading to rMAS. The Fas (CD95)/Fas ligand (CD95 ligand) system functions in turning off immune responses by executing activation-induced cell death (AICD). Soluble Fas (sFas) and Fas ligand (sFasL) can interfere with their corresponding membrane-bound counterparts, qualifying them as potential parameters of impaired immune termination. Hence, sFas and sFasL were analyzed in sera of rMAS patients. We show that soluble Fas/CD95 (sFas) is elevated >2 SD over the mean of controls in all 8 rMAS episodes studied (mean 12.08 +/- 6.12 ng/mL, range 3.7-20.2; controls 2.46 +/- 0.49, range 1.5-2.9). sFasL was detected during five rMAS episodes (0.70 +/- 0.49 ng/mL, range 0.16-1.28; controls all below the limit of detection of 0.1). In addition, both parameters decrease during convalescence, reflecting clinical evolution. In conclusion, sFas seems to be consistently elevated during acute rMAS. sFasL is detected only in a subgroup of our adult rMAS patients extending the recent finding of sFasL elevation in a majority of children with macrophage activation syndromes (Hasegawa et al. Blood 1998;91(8):2793-2799). By interfering with AICD, sFas and sFasL might contribute to the pathogenesis of at least a subset of rMAS.
18
Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas Molecule
Jianhua Cheng, Tong Zhou, Changdan Liu et al. · Science · 1994 · 1.1K citations
Masato Tanaka, Takashi Suda, Kyosuke Haze et al. · Nature Medicine · 1996 · 681 citations